High-power, High-frequency Ho:YAG Lasers Are Not Essential for Retrograde Intrarenal Surgery

Vincent De Coninck; Robert Hente; Marc Claessens; Aline Duchateau; Steeve Doizi; Etienne Xavier Keller

doi:10.1016/j.euf.2020.12.007

High-power, High-frequency Ho:YAG Lasers Are Not Essential for Retrograde Intrarenal Surgery

Eur Urol Focus. 2021 Jan;7(1):5-6. doi: 10.1016/j.euf.2020.12.007. Epub 2020 Dec 26.

Authors

Vincent De Coninck¹, Robert Hente², Marc Claessens², Aline Duchateau², Steeve Doizi³, Etienne Xavier Keller⁴

Affiliations

¹ Department of Urology, AZ Klina, Brasschaat, Belgium. Electronic address: vincent.de.coninck@klina.be.
² Department of Urology, AZ Klina, Brasschaat, Belgium.
³ Service d'Urologie, Sorbonne Université, AP-HP, Hôpital Tenon, Paris, France; Groupe de Recherche Clinique sur la Lithiase Urinaire, Sorbonne Université, Hôpital Tenon, Paris, France.
⁴ Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

PMID: 33376057
DOI: 10.1016/j.euf.2020.12.007

Abstract

There is currently insufficient in vivo evidence that high-power Ho:YAG lasers improve retrograde intrarenal surgery or the ablation efficacy. While prospective trials are awaited, a low-cost, silent, low-power Ho:YAG laser that requires only a standard electrical outlet is more than sufficient for retrograde intrarenal surgery.

MeSH terms

Humans
Lasers, Solid-State* / therapeutic use
Lithotripsy, Laser*
Ureteroscopy*
Urinary Calculi / therapy*